Citations (58)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Qisheng Xiong, Xuesong Wang, Lizhen Wang, Yan Huang, Xiaodong Tian, Yubo Fan & Chia-Ying Lin. (2018) BMP-2 inhibits lung metastasis of osteosarcoma: an early investigation using an orthotopic model. OncoTargets and Therapy 11, pages 7543-7553.
Read now
Read now
Giulia Bernardini, Marcella Laschi, Michela Geminiani & Annalisa Santucci. (2014) Proteomics of osteosarcoma. Expert Review of Proteomics 11:3, pages 331-343.
Read now
Read now
Bin Liu, Wei Ma, R. K. Jha & Kiran Gurung. (2011) Cancer stem cells in osteosarcoma: Recent progress and perspective. Acta Oncologica 50:8, pages 1142-1150.
Read now
Read now
Nino Rainusso, Tsz-Kwong Man, Ching C. Lau, John Hicks, Jianhe J. Shen, Alexander Yu, Lisa L. Wang & Jeffrey M. Rosen. (2011) Identification and gene expression profiling of tumor-initiating cells isolated from human osteosarcoma cell lines in an orthotopic mouse model. Cancer Biology & Therapy 12:4, pages 278-287.
Read now
Read now
Lin Wang, Paul Park, Huina Zhang, Frank La Marca, Amy Claeson, Juan Valdivia & Chia-Ying Lin. (2011)
BMP-2 inhibits the tumorigenicity of cancer stem cells in human osteosarcoma OS99-1 cell line
. Cancer Biology & Therapy 11:5, pages 457-463.
Read now
Read now
Chia-Ying Lin, Lin Wang, Khoi Than, Frank La Marca & Paul Park. (2010) Cancer stem cell markers: what is their diagnostic value?. Expert Opinion on Medical Diagnostics 4:6, pages 473-481.
Read now
Read now
Sameer Bakhshi & Venkatraman Radhakrishnan. (2010) Prognostic markers in osteosarcoma. Expert Review of Anticancer Therapy 10:2, pages 271-287.
Read now
Read now
Articles from other publishers (51)
Aman MouryaNavnit Prajapati. (2023) Precision Deuteration in Search of Anticancer Agents: Approaches to Cancer Drug Discovery. Cancer Biotherapy and Radiopharmaceuticals.
Crossref
Crossref
Sara R. Martins-Neves, Gabriela Sampaio-Ribeiro & Célia M. F. Gomes. (2022) Chemoresistance-Related Stem Cell Signaling in Osteosarcoma and Its Plausible Contribution to Poor Therapeutic Response: A Discussion That Still Matters. International Journal of Molecular Sciences 23:19, pages 11416.
Crossref
Crossref
Reza Noroozi, Mohammad Amin Shamekhi, Reza Mahmoudi, Ali Zolfagharian, Fatemeh Asgari, Ali Mousavizadeh, Mahdi Bodaghi, Amin Hadi & Nooshin Haghighipour. (2022) In vitro static and dynamic cell culture study of novel bone scaffolds based on 3D-printed PLA and cell-laden alginate hydrogel. Biomedical Materials 17:4, pages 045024.
Crossref
Crossref
René Rodríguez, Jiri Hatina, Stefano Gambera, Sofía T. Menéndez & Javier García-Castro. 2022. Bone Cancer. Bone Cancer
371
391
.
Baobiao Zhuo, Xihua Wang, Yang Shen, Jiayong Li, Shixian Li, Yuan Li & Rong Wang. (2021) Interleukin-24 inhibits the phenotype and tumorigenicity of cancer stem cell in osteosarcoma via downregulation Notch and Wnt/β-catenin signaling. Journal of Bone Oncology 31, pages 100403.
Crossref
Crossref
Jir-You Wang, Chao-Ming Chen, Cheng-Fong Chen, Po-Kuei Wu & Wei-Ming Chen. (2021) Suppression of Estrogen Receptor Alpha Inhibits Cell Proliferation, Differentiation and Enhances the Chemosensitivity of P53-Positive U2OS Osteosarcoma Cell. International Journal of Molecular Sciences 22:20, pages 11238.
Crossref
Crossref
Lucy E. Flint, Gregory Hamm, Joseph D. Ready, Stephanie Ling, Catherine J. Duckett, Neil A. Cross, Laura M. Cole, David P. Smith, Richard J. A. Goodwin & Malcolm R. Clench. (2021) Comparison of Osteosarcoma Aggregated Tumour Models with Human Tissue by Multimodal Mass Spectrometry Imaging. Metabolites 11:8, pages 506.
Crossref
Crossref
Romain Liénard, Monica Montesi, Silvia Panseri, Samuele Maria Dozio, Fabiana Vento, Placido G. Mineo, Anna Piperno, Julien De Winter, Olivier Coulembier & Angela Scala. (2020) Design of naturally inspired jellyfish-shaped cyclopolylactides to manage osteosarcoma cancer stem cells fate. Materials Science and Engineering: C 117, pages 111291.
Crossref
Crossref
Sukru Ozturk, Cansu Gorgun, Sevtap Gokalp, Seda Vatansever & Aylin Sendemir. (2020) Development and characterization of cancer stem cell‐based tumoroids as an osteosarcoma model. Biotechnology and Bioengineering 117:8, pages 2527-2539.
Crossref
Crossref
Abul Arif, Marc F. Hansen, Cynthia B. Alander, David K. Monson, Nickolas B. Reimer & Hicham Drissi. (2019) Cancer Stem Cells and Osteosarcoma: Opportunities and Limitations. Techniques in Orthopaedics 34:4, pages 275-286.
Crossref
Crossref
Dian Wang, Fan Bu & Weiwei Zhang. (2019) The Role of Ubiquitination in Regulating Embryonic Stem Cell Maintenance and Cancer Development. International Journal of Molecular Sciences 20:11, pages 2667.
Crossref
Crossref
May Yin Lee, Rajshekhar R. Giraddi & Wai Leong Tam. 2019. Chimera Research. Chimera Research
43
66
.
Richard Harrison, Hilda Anaid Lugo Leija, Stephanie Strohbuecker, James Crutchley, Sarah Marsh, Chris Denning, Alicia El Haj & Virginie Sottile. (2018) Development and validation of broad-spectrum magnetic particle labelling processes for cell therapy manufacturing. Stem Cell Research & Therapy 9:1.
Crossref
Crossref
Babak Otoukesh, Bahram Boddouhi, Mehdi Moghtadaei, Peyman Kaghazian & Maria Kaghazian. (2018) Novel molecular insights and new therapeutic strategies in osteosarcoma. Cancer Cell International 18:1.
Crossref
Crossref
Sandhya Moise, James M. Byrne, Alicia J. El Haj & Neil D. Telling. (2018) The potential of magnetic hyperthermia for triggering the differentiation of cancer cells. Nanoscale 10:44, pages 20519-20525.
Crossref
Crossref
Achmad Fauzi Kamal, Deded Yudha Pranatha, Waluyo Sugito, Faisal Rahman, Eka Susanto, Silmi Mariya & Wei Ming Chen. (2018) Isolation, Culture and Characterization of Cancer Stem Cells from Primary Osteosarcoma. The Open Stem Cell Journal 5:1, pages 1-13.
Crossref
Crossref
Monica Gatti, Agnese Solari, Alessandra Pattarozzi, Chiara Campanella, Stefano Thellung, Lorella Maniscalco, Raffaella De Maria, Roberto Würth, Alessandro Corsaro, Adriana Bajetto, Alessandra Ratto, Angelo Ferrari, Antonio Daga, Federica Barbieri & Tullio Florio. (2018) In vitro and in vivo characterization of stem-like cells from canine osteosarcoma and assessment of drug sensitivity. Experimental Cell Research 363:1, pages 48-64.
Crossref
Crossref
Weiwei Zhang, Yuan Zhuang, Yiran Zhang, Xiaoran Yang, Hong Zhang, Guifen Wang, Wanqi Yin, Ruifeng Wang, Zhiling Zhang & Wei Xiao. (2017) Uev1A facilitates osteosarcoma differentiation by promoting Smurf1-mediated Smad1 ubiquitination and degradation. Cell Death & Disease 8:8, pages e2974-e2974.
Crossref
Crossref
Yang Wang & Jia‑Song Teng. (2016) Increased multi‑drug resistance and reduced apoptosis in osteosarcoma side population cells are crucial factors for tumor recurrence. Experimental and Therapeutic Medicine.
Crossref
Crossref
Sara R. Martins-Neves, Willem E. Corver, Daniela I. Paiva-Oliveira, Brendy E. W. M. van den Akker, Inge H. Briaire-de-Bruijn, Judith V. M. G. Bovée, Célia M. F. Gomes & Anne-Marie Cleton-Jansen. (2016) Osteosarcoma Stem Cells Have Active Wnt/β-catenin and Overexpress SOX2 and KLF4. Journal of Cellular Physiology 231:4, pages 876-886.
Crossref
Crossref
Ander Abarrategi, Juan Tornin, Lucia Martinez-Cruzado, Ashley Hamilton, Enrique Martinez-Campos, Juan P. Rodrigo, M. Victoria González, Nicola Baldini, Javier Garcia-Castro & Rene Rodriguez. (2016) Osteosarcoma: Cells-of-Origin, Cancer Stem Cells, and Targeted Therapies. Stem Cells International 2016, pages 1-13.
Crossref
Crossref
Tomohiro Fujiwara & Toshifumi Ozaki. (2016) Overcoming Therapeutic Resistance of Bone Sarcomas: Overview of the Molecular Mechanisms and Therapeutic Targets for Bone Sarcoma Stem Cells. Stem Cells International 2016, pages 1-13.
Crossref
Crossref
Dong‑Xiu Sun, Guang‑Jun Liao, Ke‑Gui Liu & Han Jian. (2015) Endosialin‑expressing bone sarcoma stem‑like cells are highly tumor‑initiating and invasive. Molecular Medicine Reports.
Crossref
Crossref
LAN-MEI LIU, HONG-AI SUN, XIAO LI, YANG CHEN, BAO-FU WEI & XIU-JU LI. (2015) Cluster of differentiation 44- and octamer-binding transcription factor-4-positive stem-like osteosarcoma cells involved in tumor development. Oncology Letters 10:1, pages 273-276.
Crossref
Crossref
Xiaochen Zhou, Gongxian Wang & Yi Sun. (2015) A Reliable Parameter to Standardize the Scoring of Stem Cell Spheres. PLOS ONE 10:5, pages e0127348.
Crossref
Crossref
Manuela Salerno, Sofia Avnet, Gloria Bonuccelli, Shigekuni Hosogi, Donatella Granchi & Nicola Baldini. (2014) Impairment of Lysosomal Activity as a Therapeutic Modality Targeting Cancer Stem Cells of Embryonal Rhabdomyosarcoma Cell Line RD. PLoS ONE 9:10, pages e110340.
Crossref
Crossref
Patrice Penfornis, David Z. Cai, Michael R. Harris, Ryan Walker, David Licini, Joseph D. A. Fernandes, Griffin Orr, Tejaswi Koganti, Chindo Hicks, Spandana Induru, Mark S. Meyer, Rama Khokha, Jennifer Barr & Radhika R. Pochampally. (2014) High CD49f expression is associated with osteosarcoma tumor progression: a study using patient‐derived primary cell cultures. Cancer Medicine 3:4, pages 796-811.
Crossref
Crossref
Riccardo Di Fiore, Michela Marcatti, Rosa Drago-Ferrante, Antonella D'Anneo, Michela Giuliano, Daniela Carlisi, Anna De Blasio, Francesca Querques, Lucio Pastore, Giovanni Tesoriere & Renza Vento. (2014) Mutant p53 gain of function can be at the root of dedifferentiation of human osteosarcoma MG63 cells into 3AB-OS cancer stem cells. Bone 60, pages 198-212.
Crossref
Crossref
Lisa Y. Pang, Emma L. Gatenby, Ayako Kamida, Bruce A. Whitelaw, Ted R. Hupp & David J. Argyle. (2014) Global Gene Expression Analysis of Canine Osteosarcoma Stem Cells Reveals a Novel Role for COX-2 in Tumour Initiation. PLoS ONE 9:1, pages e83144.
Crossref
Crossref
Mojdeh Safari. (2014) An overview of the role of cancer stem cells in spine tumors with a special focus on chordoma. World Journal of Stem Cells 6:1, pages 53.
Crossref
Crossref
Madonna M. McManus, Kurt R. Weiss & Dennis P. M. Hughes. 2014. Current Advances in Osteosarcoma. Current Advances in Osteosarcoma
67
92
.
Ling Yu, Shiqing Liu, Chun Zhang, Bo Zhang, Bruno M. Simões, Rachel Eyre, Yi Liang, Huichao Yan, Zheng Wu, Weichun Guo & Robert B. Clarke. (2013) Enrichment of human osteosarcoma stem cells based on hTERT transcriptional activity. Oncotarget 4:12, pages 2326-2338.
Crossref
Crossref
Upal Basu-Roy, Claudio Basilico & Alka Mansukhani. (2013) Perspectives on cancer stem cells in osteosarcoma. Cancer Letters 338:1, pages 158-167.
Crossref
Crossref
MANUELA SALERNO, SOFIA AVNET, GLORIA BONUCCELLI, ADRIANA ERAMO, RUGGERO DE MARIA, MARCO GAMBAROTTI, GABRIELLA GAMBERI & NICOLA BALDINI. (2013) Sphere-forming cell subsets with cancer stem cell properties in human musculoskeletal sarcomas. International Journal of Oncology 43:1, pages 95-102.
Crossref
Crossref
Riccardo Di Fiore, Daniele Fanale, Rosa Drago-Ferrante, Ferdinando Chiaradonna, Michela Giuliano, Anna De Blasio, Valeria Amodeo, Lidia R. Corsini, Viviana Bazan, Giovanni Tesoriere, Renza Vento & Antonio Russo. (2013) Genetic and molecular characterization of the human Osteosarcoma 3AB-OS cancer stem cell line: A possible model for studying osteosarcoma origin and stemness. Journal of Cellular Physiology 228:6, pages 1189-1201.
Crossref
Crossref
Shan-Yong Yi, Yi-Bin Hao, Ke-Jun Nan & Tian-Li Fan. (2013) Cancer stem cells niche: A target for novel cancer therapeutics. Cancer Treatment Reviews 39:3, pages 290-296.
Crossref
Crossref
Sara R Martins-Neves, Áurio O Lopes, Anália do Carmo, Artur A Paiva, Paulo C Simões, Antero J Abrunhosa & Célia MF Gomes. (2012) Therapeutic implications of an enriched cancer stem-like cell population in a human osteosarcoma cell line. BMC Cancer 12:1.
Crossref
Crossref
Fergal C. Kelleher, Jason E. Cain, Joan M. Healy, D. Neil Watkins & David M. Thomas. (2012) Prevailing importance of the hedgehog signaling pathway and the potential for treatment advancement in sarcoma. Pharmacology & Therapeutics 136:2, pages 153-168.
Crossref
Crossref
Lin Wang, Paul Park, Huina Zhang, Frank La Marca, Amy Claeson, Khoi Than, Shayan Rahman & Chia-Ying Lin. (2012) BMP-2 inhibits tumor growth of human renal cell carcinoma and induces bone formation. International Journal of Cancer 131:8, pages 1941-1950.
Crossref
Crossref
AINA HE, WEIXIANG QI, YUJING HUANG, TAO FENG, JIE CHEN, YUANJUE SUN, ZAN SHEN & YANG YAO. (2012) CD133 expression predicts lung metastasis and poor prognosis in osteosarcoma patients: A clinical and experimental study. Experimental and Therapeutic Medicine 4:3, pages 435-441.
Crossref
Crossref
Wesley Hsu, Ahmed Mohyeldin, Sagar R. Shah, Ziya L. Gokaslan & Alfredo Quinones-Hinojosa. (2012) Role of Cancer Stem Cells in Spine Tumors. Neurosurgery 71:1, pages 117-125.
Crossref
Crossref
Barbara Dozza, Alessio Papi, Enrico Lucarelli, Katia Scotlandi, Michela Pierini, Giuseppina Tresca, Davide Donati & Marina Orlandi. (2012) Cell growth inhibition and apoptotic effect of the rexinoid 6-OH-11-O-hydroxyphenantrene on human osteosarcoma and mesenchymal stem cells. Toxicology in Vitro 26:1, pages 142-149.
Crossref
Crossref
Lin Wang, Paul Park, Frank La Marca, Khoi Than, Shayan Rahman & Chia-Ying Lin. (2012) Advancements in Suppression of Osteosarcoma Tumorigenicity: A Prospective Look. Journal of Cancer Therapy 03:04, pages 327-330.
Crossref
Crossref
GUI-QIN LING, DONG-BO CHEN, BAO-QING WANG & LAN-SHENG ZHANG. (2012) Expression of the pluripotency markers Oct3/4, Nanog and Sox2 in human breast cancer cell lines. Oncology Letters 4:6, pages 1264-1268.
Crossref
Crossref
Wen Zeng, Rong Wan, Yuehuan Zheng, Shree Ram Singh & Yiyong Wei. (2011) Hypoxia, stem cells and bone tumor. Cancer Letters 313:2, pages 129-136.
Crossref
Crossref
Laura Saldaña, Fátima Bensiamar, Alba Boré & Nuria Vilaboa. (2011) In search of representative models of human bone-forming cells for cytocompatibility studies. Acta Biomaterialia 7:12, pages 4210-4221.
Crossref
Crossref
Scott Russinoff, Sara Miran, Ashok L. Gowda & Paul A. Lucas. (2011) Osteosarcoma Cells Differentiate into Phenotypes from all Three Dermal Layers. Clinical Orthopaedics & Related Research 469:10, pages 2895-2904.
Crossref
Crossref
Ilaria Chiodi, Cristina Belgiovine, Francesca Donà, A. Ivana Scovassi & Chiara Mondello. (2011) Drug Treatment of Cancer Cell Lines: A Way to Select for Cancer Stem Cells?. Cancers 3:1, pages 1111-1128.
Crossref
Crossref
Sara Ci Neves, Vitor Eb Oliveira, Analia do Carmo, Antero J Abrunhosa, M Filomena Botelho & Celia Mf Gomes. (2011) Elucidation of the drug resistance mechanisms of osteosarcoma cancer stem cells with PET tracers. Elucidation of the drug resistance mechanisms of osteosarcoma cancer stem cells with PET tracers.
Gregory K. Friedman & G. Yancey Gillespie. (2011) Cancer Stem Cells and Pediatric Solid Tumors. Cancers 3:1, pages 298-318.
Crossref
Crossref
Masataka Hirotsu, Takao Setoguchi, Hiromi Sasaki, Yukihiro Matsunoshita, Hui Gao, Hiroko Nagao, Osamu Kunigou & Setsuro Komiya. (2010) Smoothened as a new therapeutic target for human osteosarcoma. Molecular Cancer 9:1.
Crossref
Crossref